Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

CSF1R inhibitors exhibit anti-tumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.

Edwards DK 5th, Watanabe-Smith K, Rofelty A, Damnernsawad A, Laderas T, Lamble A, Lind EF, Kaempf A, Mori M, Rosenberg M, d'Almeida A, Long N, Agarwal A, Sweeney DT, Loriaux M, McWeeney SK, Tyner JW.

Blood. 2018 Nov 13. pii: blood-2018-03-838946. doi: 10.1182/blood-2018-03-838946. [Epub ahead of print]

PMID:
30425048
2.

IFN╬│-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.

Lane RS, Femel J, Breazeale AP, Loo CP, Thibault G, Kaempf A, Mori M, Tsujikawa T, Chang YH, Lund AW.

J Exp Med. 2018 Oct 31. pii: jem.20180654. doi: 10.1084/jem.20180654. [Epub ahead of print]

PMID:
30381467
3.

Specific Tumor Characteristics Predict Upstaging in Early-Stage Esophageal Cancer.

Haisley KR, Hart CM, Kaempf AJ, Dash NR, Dolan JP, Hunter JG.

Ann Surg Oncol. 2018 Oct 30. doi: 10.1245/s10434-018-6804-z. [Epub ahead of print]

PMID:
30377918
4.

Functional genomic landscape of acute myeloid leukaemia.

Tyner JW, Tognon CE, Bottomly D, Wilmot B, Kurtz SE, Savage SL, Long N, Schultz AR, Traer E, Abel M, Agarwal A, Blucher A, Borate U, Bryant J, Burke R, Carlos A, Carpenter R, Carroll J, Chang BH, Coblentz C, d'Almeida A, Cook R, Danilov A, Dao KT, Degnin M, Devine D, Dibb J, Edwards DK 5th, Eide CA, English I, Glover J, Henson R, Ho H, Jemal A, Johnson K, Johnson R, Junio B, Kaempf A, Leonard J, Lin C, Liu SQ, Lo P, Loriaux MM, Luty S, Macey T, MacManiman J, Martinez J, Mori M, Nelson D, Nichols C, Peters J, Ramsdill J, Rofelty A, Schuff R, Searles R, Segerdell E, Smith RL, Spurgeon SE, Sweeney T, Thapa A, Visser C, Wagner J, Watanabe-Smith K, Werth K, Wolf J, White L, Yates A, Zhang H, Cogle CR, Collins RH, Connolly DC, Deininger MW, Drusbosky L, Hourigan CS, Jordan CT, Kropf P, Lin TL, Martinez ME, Medeiros BC, Pallapati RR, Pollyea DA, Swords RT, Watts JM, Weir SJ, Wiest DL, Winters RM, McWeeney SK, Druker BJ.

Nature. 2018 Oct;562(7728):526-531. doi: 10.1038/s41586-018-0623-z. Epub 2018 Oct 17.

PMID:
30333627
5.

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.

Kurtz SE, Eide CA, Kaempf A, Mori M, Tognon CE, Borate U, Druker BJ, Tyner JW.

Leukemia. 2018 Sep;32(9):2025-2028. doi: 10.1038/s41375-018-0225-7. Epub 2018 Aug 6. No abstract available.

PMID:
30082821
6.

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.

Hosseini MM, Kurtz SE, Abdelhamed S, Mahmood S, Davare MA, Kaempf A, Elferich J, McDermott JE, Liu T, Payne SH, Shinde U, Rodland KD, Mori M, Druker BJ, Singer JW, Agarwal A.

Leukemia. 2018 Mar 29. doi: 10.1038/s41375-018-0112-2. [Epub ahead of print]

PMID:
29743719
7.

Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas.

Lu E, Perlewitz KS, Hayden JB, Hung AY, Doung YC, Davis LE, Mansoor A, Vetto JT, Billingsley KG, Kaempf A, Park B, Ryan CW.

Ann Surg Oncol. 2018 Apr;25(4):920-927. doi: 10.1245/s10434-018-6346-4. Epub 2018 Jan 31.

PMID:
29388122
8.

Modulation of UVB-induced Carcinogenesis by Activation of Alternative DNA Repair Pathways.

Sha Y, Vartanian V, Owen N, Mengden Koon SJ, Calkins MJ, Thompson CS, Mirafzali Z, Mir S, Goldsmith LE, He H, Luo C, Brown SM, Doetsch PW, Kaempf A, Lim JY, McCullough AK, Lloyd RS.

Sci Rep. 2018 Jan 15;8(1):705. doi: 10.1038/s41598-017-17940-8.

9.

Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.

Kurtz SE, Eide CA, Kaempf A, Khanna V, Savage SL, Rofelty A, English I, Ho H, Pandya R, Bolosky WJ, Poon H, Deininger MW, Collins R, Swords RT, Watts J, Pollyea DA, Medeiros BC, Traer E, Tognon CE, Mori M, Druker BJ, Tyner JW.

Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7554-E7563. doi: 10.1073/pnas.1703094114. Epub 2017 Aug 7.

10.

Gender and the experience of mental health expert witness testimony.

Kaempf AC, Baxter P, Packer IK, Pinals DA.

J Am Acad Psychiatry Law. 2015 Mar;43(1):52-9.

PMID:
25770280
11.

Delayed umbilical cord clamping in premature neonates.

Kaempf JW, Tomlinson MW, Kaempf AJ, Wu Y, Wang L, Tipping N, Grunkemeier G.

Obstet Gynecol. 2012 Aug;120(2 Pt 1):325-30. doi: 10.1097/AOG.0b013e31825f269f.

PMID:
22825092
12.

What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?

Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G.

J Perinatol. 2012 May;32(5):344-8. doi: 10.1038/jp.2011.102. Epub 2011 Aug 4.

PMID:
21818064
13.

Hyperglycemia, insulin and slower growth velocity may increase the risk of retinopathy of prematurity.

Kaempf JW, Kaempf AJ, Wu Y, Stawarz M, Niemeyer J, Grunkemeier G.

J Perinatol. 2011 Apr;31(4):251-7. doi: 10.1038/jp.2010.152. Epub 2011 Jan 13.

PMID:
21233796

Supplemental Content

Loading ...
Support Center